REFERENCES
- Aiello L P, George D J, Cahill M T, Wong J S, Cavallerano J, Hannah A L, Kaelin W G. Rapid and durable recovery of visual function in a patient with von Hippel-Lindau syndrome after systemic therapy with vascular endothelial growth factor receptor inhibitor SU5416. Ophthalmology 2002; 109: 1745–51, [INFOTRIEVE], [CSA]
- Annesley W J, Leonard B C, Shields J A, Tasman W S. Fifteen year review of treated cases of retinal angiomatosis. Trans Am Acad Ophthalmol Otolaryngol 1977; 83: 446–53, [CSA]
- Binkovitz L A, Johnson C D, Stephens D H. Islet cell tumors in von Hippel-Lindau disease: increased prevalence and relationship to the multiple endocrine neoplasias. Am J Roentgenol 1990; 155: 501–5, [CSA]
- Blondi C F, Russell S R, Pulido J S, Folk J C. Direct and feeder vessel photocoagulation of retinal angiomas with dye yellow laser. Ophthalmology 1990; 97: 791–7, [CSA]
- Chan C C, Vortmeyer A O, Chew E Y, et al. VHL gene deletion and enhanced VEGF gene expression detected in the stromal cells of retinal angioma. Arch Ophthalmol 1999; 117: 625–30, [INFOTRIEVE], [CSA]
- Chang J H, Spraul C W, Lynn M L, et al. The two-stage mutation model in retinal hemangioblastoma. Ophthalmic Genet 1998; 19: 123–30, [INFOTRIEVE], [CSA], [CROSSREF]
- Choyke P L, Glenn G M, Walther M M, et al. The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. Am J Roentgenol 1992; 159: 1229–34, [CSA]
- Choyke P L, Glenn G M, Walther M M, et al. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 1995; 194: 629–42, [INFOTRIEVE], [CSA]
- Choyke P L, Glenn G M, Wagner J P, et al. Epididymal cystadenoma in von Hippel-Lindau disease. Urology 1997; 49: 926–31, [INFOTRIEVE], [CSA], [CROSSREF]
- Filling-Katz M R, Choyke P L, Oldfield E, et al. Central nervous system involvement in von Hippel-Lindau disease. Neurology 1991; 41: 41–6, [INFOTRIEVE], [CSA]
- Gass J D. Cavernous hemangioma of the retina. A neuro-oculo-cutaneous syndrome. Am J Ophthalmol 1971; 71: 799–14, [INFOTRIEVE], [CSA]
- Gass J DM. Treatment of retinal vascular anomalies. Trans Am Acad Ophthalmol Otolaryngol 1977; 83: 432–42, [CSA]
- Gass J D, Braunstein R. Sessile and exophytic capillary angiomas of the juxtapapillary retina and optic nerve head. Arch Ophthalmol 1980; 98: 1790–7, [INFOTRIEVE], [CSA]
- Girmens J F, Erginay A, Massin P, Scigalla P, Gandric A, Richard S. Treatment of von Hippel-Lindau retinal hemangioblastoma by the vascular endothelial growth factor receptor inhibitor SU5416 is more effective for associated macular edema than for hemangioblastomas. Am J Ophthalmol 2003; 136: 194–6, [INFOTRIEVE], [CSA], [CROSSREF]
- Goldberg M F, Duke J R. von Hippel-Lindau disease. Histopathologic findings in a treated and an untreated eye. Am J Ophthalmol 1968; 66: 693–05, [INFOTRIEVE], [CSA]
- Harbour J W. Tumor suppressor genes in ophthalmology. Surv Ophthalmol 1999; 44: 235–46, [INFOTRIEVE], [CSA], [CROSSREF]
- Harris A L. von Hippel-Lindau syndrome. Target for anti-vascular endothelial growth factor (VEGF) receptor therapy. The Oncologist 2000; 5(suppl)32–36, [INFOTRIEVE], [CSA], [CROSSREF]
- Heimann H, Bornfeld N, Vij O, Coupland S E, Bechrakis N E, Kellner U, Forester M H. Vasoproliferative tumors of the retina. Br J Ophthalmol 2000; 84: 1162–9, [INFOTRIEVE], [CSA], [CROSSREF]
- Hough D M, Stephens D H, Johnson C D, Binkovitz L A. Pancreatic lesions in von Hippel-Lindau disease: prevalence, clinical significance, and CT findings. Am J Roentgenol 1994; 162: 1091–4, [CSA]
- Jakobiec F A, Font R L, Johnson F B. Angiomatosis retinae. An ultrastructural study and lipid analysis. Cancer 1976; 38: 2042–56, [INFOTRIEVE], [CSA], [CROSSREF]
- Kaelin W G, Sr, Maher E R. The VHL tumor-suppressor gene paradigm. Trends Genet 1998; 14: 423–6, [INFOTRIEVE], [CSA], [CROSSREF]
- Krusel K M, Bornfeld N, Lommatzsch A, et al. Ruthenium-106 brachytherapy for peripheral retinal capillary hemangioma. Ophthalmology 1998; 105: 1386–92, [CSA], [CROSSREF]
- Lee J Y, Dong S M, Park W S, et al. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. Cancer Res 1998; 58: 504–8, [INFOTRIEVE], [CSA]
- Libutti S K, Choyke P L, Bartlett D L, et al. Pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease: diagnostic and management recommendations. Surgery 1998; 124: 1153–9, [INFOTRIEVE], [CSA], [CROSSREF]
- Maher E R, Yates J R, Harries R, et al. Clinical features and natural history of von Hippel-Lindau disease. Q Journal Medicine 1990; 77: 1151–65, [CSA]
- Maher E R, Lselius L, Yates J R, et al. von Hippel-Lindau disease: a genetic study. J Med Genet 1991; 28: 443–7, [INFOTRIEVE], [CSA]
- Malek R S, Omess P J, Benson R C, Jr, Zincke H. Renal cell carcinoma in von Hippel-Lindau syndrome. Am J Med 1987; 82: 236–8, [INFOTRIEVE], [CSA], [CROSSREF]
- McCage C M, Lynn H W, Shields C L, Shields J A, Regillo C D, McDonald R, Berrocal M H, Gass J DM, Mieler W F. Juxtapapillary capillary hemangioma. Ophthalmology 2000; 107: 2240–49, [CSA], [CROSSREF]
- Neumann H P, Eggert H R, Weigel K, et al. Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 1989; 70: 24–30, [INFOTRIEVE], [CSA]
- Neumann H P, Berger D P, Sigmund G, et al. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease. N Engl J Med 1993; 329: 1531–8, [INFOTRIEVE], [CSA], [CROSSREF]
- Oosterhuis J A, Rubinstein K. Haemangioma of the optic disc. Ophthalmologica, 164: 362–74, 1[CSA]
- Palmer J D, Gragoudas E S. Advances in treatment of retinal angiomas. Int Ophthalmol Clin 1997; 37: 150–70, [CSA]
- Peyman G A, Raichand M, Zeimer R C. Ocular effects of various laser wavelengths. Surv Ophthalmol 1984; 28: 391–404, [INFOTRIEVE], [CSA], [CROSSREF]
- Ridley M, Green J, Johnson G. Retinal angiomatosis: the ocular manifestations of von Hippel-Lindau disease. Can J Ophthalmol 1986; 21: 276–83, [INFOTRIEVE], [CSA]
- Rurbazetto I A, Schmidt-Erfarth U M. Photodynamic therapy in the treatment of intraocular angioma (abstract). Presented at the American Academy of Ophthalmol, Orlando, FL, 1999
- Schmidt D, Natt E, Neumann H P. Long-term results of laser treatment for retinal angiomatosis in von Hippel-Lindau disease. Eur J Med Res 2000; 5: 47–58, [INFOTRIEVE], [CSA]
- Shields C L, Shields J A, Barrett J, et al. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol 1995; 113: 615–23, [INFOTRIEVE], [CSA]
- Shields C L, Shields J A, Barrett J, DePotter P. Vasoproliferative tumors of the ocular fundus. Classification and clinical manifestations in 103 patients. Arch Ophthalmol 1995; 113: 615–23, [INFOTRIEVE], [CSA]
- Shields C L, Shields J A, DePotter P. Patterns of indocyanine green videoangiography of choroidal tumors. Br J Ophthalmol 1995; 79: 237–45, [INFOTRIEVE], [CSA]
- Sigelman J. Retinal Diseases. Pathogenesis, laser therapy and surgery. Little Brown and Company, Boston 1984; 316
- Singh A D, Shields C L, Shields J A. von Hippel-Lindau disease. Surv Ophthalmol 2001; 46: 117–142, [INFOTRIEVE], [CSA], [CROSSREF]
- Singh A D, Nouri M, Shields C L, Shields J A, Perez N. Treatment of retinal capillary hemangioma. Ophthalmology 2002; 109: 1799–1806, [INFOTRIEVE], [CSA], [CROSSREF]
- Vail D. Angiomatosis retinae, eleven years after diathermy coagulation. AJ Ophthalmol 1958; 46: 525–34, [CSA]
- Via L E, Gore-Langton R E, Pluda J M. Clinical trials referral resource. Current clinical trials administering the antiangiogenesis agent SU5416. Oncology 2000; 14: 1312, 1315–6, 1321–3[INFOTRIEVE], [CSA]
- Webster A R, Richards F M, MacRonald F E, et al. An analysis of phenotypic variation in the familial cancer syndrome von Hippel-Lindau disease: evidence for modifier effects. Am J Hum Genet 1998; 63: 1025–35, [INFOTRIEVE], [CSA], [CROSSREF]
- Webster A R, Maher E R, Moore A T. Clinical characteristics of ocular angiomatosis in von Hippel-Lindau disease and correlation with germline mutation. Arch Ophthalmol 1999; 117: 371–8, [INFOTRIEVE], [CSA]
- Whitson J T, Welch R B, Green W R. von Hippel-Lindau disease: case report of a patient with spontaneous regression of a retinal angioma. Retina 1986; 6: 253–9, [INFOTRIEVE], [CSA]
- Wittebol-Post D, Hes F T, Lips C J. The eye in von Hippel-Lindau disease. Long-term follow-up of screening and treatment: recommendations. J Intern Med 1998; 243: 555–61, [INFOTRIEVE], [CSA], [CROSSREF]
- Wing G L, Weiter J J, Kelly P J, et al. von Hippel-Lindau disease: angiomatosis of the retina and central nervous system. Ophthalmology 1981; 88: 1311–4, [INFOTRIEVE], [CSA]